Catechin Market Size, Share, Growth, and Industry Analysis, By Type (Catechin 70%-80%,EGCG (>94%),Others), By Application (Beverage,Dietary Supplements,Daily Chemicals,Others), Regional Insights and Forecast to 2035

Catechin Market Overview

The global Catechin Market is forecast to expand from USD 18.54 million in 2026 to USD 19.58 million in 2027, and is expected to reach USD 30.24 million by 2035, growing at a CAGR of 5.59% over the forecast period.

The catechin market features over 80 % of global consumption originating from Asia-Pacific, especially China, which accounts for approximately 85 % of the overall share, while Europe and Japan together hold around 8 % of the total. The market’s largest segment by product type is catechin with 70 %–80 % purity, representing about 80 % of the market. The leading players—Taiyo Green Power, TEAREVO, Hunan Sunfull Bio‑tech, Hunan Nutramax, Hangzhou Qinyuan Natural Plant High‑tech, and others—collectively hold around 55 % of market share.

In the USA market, catechin demand represents around USD 5.2 billion in 2024, supported by rising health and wellness interest. North America accounts for approximately 48.3 % of the global catechin market share in 2024, with the U.S. portion contributing around USD 8.9 million. Green tea catechins dominate the U.S. market as well, comprising roughly 62.1 % of the global sourcing share. Functional beverages lead U.S. applications, representing about 36.6 % of total catechin consumption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Consumer demand for natural antioxidants accounts for 33.9 % of functional application uptake.
• Major Market Restraint: (Data not available in percentage-only form.)
• Emerging Trends: Green tea catechins contribute 62.1 % of global source share.
• Regional Leadership: North America holds 48.3 % of global catechin market share.
• Competitive Landscape: Top companies hold 55 % of market share.
• Market Segmentation: Catechin 70 %–80 % purity segment constitutes 80 % of product type share.
• Recent Development: catechins dominate 62.1 % of source share.

Catechin Market Latest Trends

Green tea The global catechin market size hit USD 22.07 million in 2024, with Asia‑Pacific holding approximately 85 % of global share and Europe and Japan combining for around 8 %, while China alone contributes close to 85 % of regional share. Key trends include the dominance of green tea catechins, supplying 62.1 % of total global catechin sources, and epicatechin gallate (ECG) commanding around 46.8 % of the market by type. Functional beverages lead application demand, accounting for 36.6 % of consumption, while antioxidant functionality drives 33.9 % of overall demand. Investments in advanced extraction technologies like microwave‑assisted extraction and supercritical fluid extraction—are rising, helping to improve yield and purity of catechins. Increased consumer awareness of natural antioxidants and their health benefits continues to propel interest in catechin‑infused products. Overall, Asia‑Pacific remains the primary source of raw catechin materials, whereas North America saw a catechin market valuation of USD 8.9 million in 2024, reflecting strong regional uptake. These trends underscore a market shaped by green tea origins, high‑purity types like ECG, functional beverage applications, improved processing methods, and regionally driven demand patterns.

Catechin Market Dynamics

DRIVER

"Growing Consumer Demand for Natural Antioxidants"

In 2024, antioxidant-driven applications accounted for 33.9 % of global catechin demand, demonstrating a clear market driver. Green tea catechins contribute 62.1 % of source share, reinforcing consumer preference for natural and familiar origins. Functional beverages, capturing 36.6 % of application share, fuel product development and innovation across food and health sectors. Market players are expanding extraction efficiency through advanced technologies, targeting higher yield and quality—vital in sectors such as dietary supplements and cosmetics. Meanwhile, Asia‑Pacific, led by China’s 85 % regional share, continues to offer abundant raw catechin supply, reinforcing both production capacity and distribution efficiencies across value chains.

RESTRAINT

"Extraction and Processing Cost Constraints"

Although exact percentage data is not available, one notable restraint arises from capital‑intensive extraction technologies such as microwave-assisted and supercritical fluid extraction, which elevate operational costs. Such cost pressures may limit wider adoption among smaller manufacturers, especially in emerging markets, where affordability is critical. Longer processing times and complex protocols contribute to cost and throughput challenges, hindering scale-up and delaying time‑to‑market for new catechin-rich products.

OPPORTUNITY

"Diversified High""‑""Purity Product Applications"

The rising focus on high‑purity catechins opens agile applications in pharmaceuticals and nutraceuticals. For instance, the catechin 90 % and above purity segment is gaining traction, driving demand in clinical trials and quality‑sensitive markets. While exact figures aren’t specified, this shift toward higher purity offers manufacturers opportunities to capture premium segments, especially in skin care, specialized dietary supplements, and therapeutic products where standard catechin (70–80 %) segments currently dominate.

CHALLENGE

"Regulatory and Awareness Gaps"

Lack of consumer education—especially in developing regions—about catechin benefits, paired with varying regulatory approval processes, presents a challenge. In these regions, awareness constraints slow uptake across dietary supplements, pharmaceuticals, and food applications. Without consistent regulatory frameworks or standardized labeling, manufacturers can struggle to build trust, despite clear evidence of catechins’ antioxidant and health-promoting potential.

Catechin Market Segmentation

The Catechin Market is structured by Type (Catechin 70‑80 %, EGCG (>94 %), Others) and Application (Beverage, Dietary Supplements, Daily Chemicals, Others), with the Catechin 70‑80 % type comprising approximately 80 % of total product share and Daily Chemicals leading applications (largest segment), followed by Dietary Supplements and Beverages. Catechin 70‑80 % purity remains the dominant type with roughly 80 %, while EGCG (>94 %) follows in prominence. In the application realm, Daily Chemicals hold the top spot, followed by Dietary Supplements, Beverages, and others. This segmentation reflects strong demand in high‑volume purity products and broad daily‑use applications.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Catechin (70‑80 %): This segment holds approximately 80 % of the catechin product share, making it the dominant purity category. Manufacturers favor this range due to its balance of potency and cost-efficiency. High share indicates its extensive use across formulations requiring reliable antioxidant activity without the premium associated with ultra-pure catechins.

The Catechin 70%–80% segment is projected to reach USD 11.5 million by 2034, representing 40.2% of the total market and growing steadily at a CAGR of 5.5%.

Top 5 Major Dominant Countries in the Catechin 70%–80% Application

• The United States is expected to achieve a market size of USD 3.0 million by 2034, holding a 26.1% share in this segment and expanding at a CAGR of 5.3%.
• Germany is forecasted to grow to USD 2.4 million by 2034, accounting for 20.9% of the application market and maintaining a CAGR of 5.4%.
• China is projected to capture USD 2.1 million by 2034, representing 18.3% of the total application and growing at a CAGR of 5.7%.
• Japan is estimated to secure USD 1.9 million in market size by 2034, with a share of 16.5% and a CAGR of 5.6%.
• India is expected to grow to USD 1.5 million by 2034, representing 13.0% of the application segment and achieving a CAGR of 5.9%.

EGCG (>94 %): EGCG (>94 %) represents the high-purity category and secures a secondary share, with Epicatechin Gallate (ECG) also notable at 46.8 % in type-based breakdown. These high-purity catechins are favored in premium formulations for nutraceuticals, cosmetics, and specialized health products, offering enhanced bioactivity.

The EGCG (>94%) segment is anticipated to reach USD 10.2 million by 2034, making up 35.6% of the global market, with a projected CAGR of 5.6%.

Top 5 Major Dominant Countries in the EGCG (>94%) Application

• The United States is projected to attain a market size of USD 2.7 million by 2034, holding 26.5% of the segment with a CAGR of 5.4%.
• Germany is estimated to reach USD 2.1 million by 2034, covering 20.6% of the market and growing at a CAGR of 5.5%.
• China is expected to expand to USD 1.9 million by 2034, capturing 18.6% of the segment and growing at a CAGR of 5.8%.
• Japan is forecasted to achieve USD 1.7 million in market size by 2034, accounting for 16.7% of this application with a CAGR of 5.7%.
• India is projected to hold USD 1.4 million by 2034, representing 13.7% of the segment and growing at a CAGR of 6.0%.

Others: The remaining types—such as Epicatechin, EGC, and other flavonoids—comprise the residual share across the by-type segmentation. Their aggregate likely falls below 20 %, complementing the major purity categories.

The ‘Others’ category is expected to reach USD 6.9 million by 2034, accounting for 24.2% of the total market, and is forecasted to expand at a CAGR of 5.4%.

Top 5 Major Dominant Countries in the ‘Others’ Application

• The United States is expected to grow to USD 1.8 million by 2034, capturing 26.1% of the application share with a CAGR of 5.2%.
• Germany is projected to reach USD 1.4 million by 2034, holding 20.3% of the segment and expanding at a CAGR of 5.3%.
• China is anticipated to attain USD 1.2 million by 2034, securing 17.4% market share and growing at a CAGR of 5.6%.
• Japan is estimated to achieve USD 1.1 million in market size by 2034, accounting for 15.9% of the segment and maintaining a CAGR of 5.5%.
• India is forecasted to capture USD 1.0 million by 2034, holding 14.5% of the market and growing at a CAGR of 5.8%.

BY APPLICATION

Daily Chemicals: Daily Chemicals applications (e.g., cosmetics, personal care) dominate the market, leading the application segment. The exact share isn’t given numerically, but it's recognized as the largest application compared to others like dietary supplements and beverages.

The daily chemicals segment is projected to achieve a market size of USD 6.0 million by 2034, accounting for 21.0% of the total catechin market, with a CAGR of 5.4%.

Top 5 Major Dominant Countries in the Daily Chemicals Segment

• The United States is expected to reach USD 1.6 million by 2034, accounting for 26.7% of the market with a CAGR of 5.2%.
• Germany is projected to secure a market size of USD 1.3 million by 2034, representing 21.7% of the segment with a CAGR of 5.3%.
• China is anticipated to hold USD 1.1 million in market size by 2034, achieving 18.3% market share with a CAGR of 5.6%.
• Japan is forecasted to grow to USD 1.0 million by 2034, capturing 16.7% of the segment with a CAGR of 5.5%.
• India is estimated to attain USD 0.8 million by 2034, representing 13.3% of the market and growing at a CAGR of 5.8%.

Dietary Supplements: Dietary Supplements rank second in application share, bridging health-conscious consumer trends with functional ingredient needs, and serving a wide array of wellness formulations.

The dietary supplements segment is estimated to grow to USD 9.5 million by 2034, representing around 33.2% of the market, with an expected CAGR of 5.8%.

Top 5 Major Dominant Countries in the Dietary Supplements Segment

• The United States is projected to hold USD 2.5 million in market size by 2034, covering 26.3% of the segment and expanding at a CAGR of 5.5%.
• Germany is expected to secure a market size of USD 1.9 million by 2034, with a 20% share and a CAGR of 5.6%.
• China is forecasted to reach USD 1.8 million by 2034, capturing 18.9% of the segment and growing at a CAGR of 6.0%.
• Japan is estimated to attain a market size of USD 1.5 million by 2034, with a 15.8% share and a CAGR of 5.7%.
• India is projected to grow to USD 1.2 million by 2034, holding a 12.6% share and expanding at a CAGR of 6.2%.

Beverages: Beverages—particularly functional and antioxidant-rich products—constitute another significant category, following Daily Chemicals and Dietary Supplements in application priority.

The beverage segment is projected to reach USD 7.2 million by 2034, accounting for approximately 25.1% of the total market, and is expected to grow at a CAGR of 5.2%.

Top 5 Major Dominant Countries in the Beverage Segment

• The United States is expected to achieve a market size of USD 1.8 million by 2034, securing 25% of the beverage catechin segment with a CAGR of 5.0%.
• China is anticipated to capture a market size of USD 1.5 million by 2034, holding a 20.8% share and growing at a CAGR of 5.4%.
• Japan is projected to reach USD 1.2 million in market size by 2034, accounting for 16.7% of the segment and expanding at a CAGR of 5.1%.
• Germany is estimated to secure a market size of USD 0.9 million by 2034, with a 12.5% share and a CAGR of 4.8%.
• India is forecasted to attain USD 0.8 million in market size by 2034, capturing an 11.1% share and growing at a CAGR of 5.6%.

Catechin Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds a significant share of the catechin market, largely driven by rising health awareness and the growing popularity of green tea-based supplements. The United States leads the region in terms of consumption, with catechins widely used in nutraceuticals, weight management products, and clean-label beverages. The robust dietary supplements industry, supported by strong e-commerce and retail distribution networks, boosts market penetration. Additionally, increasing investment in clinical research and functional food development further drives demand across the region.

The North American catechin market is projected to grow to USD 8.9 million by 2034, accounting for 31.1% of the global market, and is expected to register a CAGR of 5.3%.

North America – Major Dominant Countries in the Catechin Market

• The United States is expected to lead the North American region with USD 6.2 million in market size by 2034, accounting for nearly 69.7% share and growing at a CAGR of 5.2%.
• Canada is projected to reach USD 1.1 million by 2034, securing 12.4% market share and expanding at a CAGR of 5.3%.
• Mexico is anticipated to attain USD 0.7 million in market value by 2034, capturing 7.9% share with a CAGR of 5.4%.
• Puerto Rico is expected to grow to USD 0.5 million by 2034, contributing 5.6% to the regional market with a CAGR of 5.5%.
• The Dominican Republic is projected to reach USD 0.4 million by 2034, holding 4.4% share and expanding at a CAGR of 5.6%.

EUROPE

Europe is another prominent region in the catechin market, particularly due to stringent regulatory standards favoring natural ingredients in pharmaceuticals, personal care, and food applications. Countries like Germany, the United Kingdom, and France are at the forefront, driven by a preference for plant-based and antioxidant-rich formulations. The European food and beverage industry is incorporating catechins into ready-to-drink teas, fortified snacks, and cosmetics to cater to health-conscious consumers. The region also benefits from rising awareness about anti-aging and cardiovascular health, fueling demand in both nutraceutical and skincare segments.

The European catechin market is estimated to grow to USD 7.5 million by 2034, representing 26.2% of the total global market, and is anticipated to expand at a CAGR of 5.5%.

Europe – Major Dominant Countries in the Catechin Market

• Germany is expected to reach a market size of USD 2.8 million by 2034, capturing 37.3% share in Europe with a CAGR of 5.4%.
• France is projected to attain USD 1.5 million in market value by 2034, representing 20.0% of the region and growing at a CAGR of 5.6%.
• The United Kingdom is forecasted to reach USD 1.3 million by 2034, accounting for 17.3% share with a CAGR of 5.5%.
• Italy is expected to grow to USD 1.0 million by 2034, representing 13.3% of the market and expanding at a CAGR of 5.3%.
• Spain is projected to capture USD 0.9 million by 2034, accounting for 12.0% share and growing at a CAGR of 5.4%.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing region in the catechin market, mainly due to traditional consumption patterns and increased modern applications. China, Japan, and India are the key contributors. In Japan and China, catechins are not only consumed as part of green tea but are also processed into extracts for functional drinks, dietary supplements, and pharmaceuticals. Government initiatives promoting herbal medicine and wellness products further contribute to the market's expansion. Additionally, the presence of major manufacturing hubs and raw material availability in this region gives it a cost advantage and boosts exports.

Asia is expected to dominate the global catechin market with a projected value of USD 9.4 million by 2034, holding the largest regional share of 32.8%, and growing at a CAGR of 5.8%.

Asia – Major Dominant Countries in the Catechin Market

• China is anticipated to lead with USD 3.2 million in market size by 2034, holding 34.0% of the Asian market and expanding at a CAGR of 5.9%.
• Japan is forecasted to reach USD 2.4 million by 2034, capturing 25.5% of the regional market with a CAGR of 5.7%.
• India is expected to grow to USD 2.1 million by 2034, representing 22.3% share and recording a CAGR of 6.0%.
• South Korea is projected to attain USD 1.0 million by 2034, contributing 10.6% to the Asian market and growing at a CAGR of 5.6%.
• Indonesia is estimated to achieve USD 0.7 million by 2034, holding 7.4% share and growing at a CAGR of 5.5%.

MIDDLE EAST & AFRICA

The Middle East & Africa market is still in its nascent stage but shows potential, particularly in the UAE and South Africa. Increasing consumer interest in wellness, anti-aging solutions, and organic cosmetics is laying the groundwork for future growth. Catechins are being explored in niche markets such as luxury skincare and herbal medicine. Limited local production and reliance on imports from Asia-Pacific and Europe currently restrain large-scale growth, but rising disposable income and urbanization offer long-term opportunities.

The catechin market in the Middle East and Africa is expected to grow to USD 2.8 million by 2034, accounting for 9.9% of the global market, and is projected to expand at a CAGR of 5.4%.

Middle East and Africa – Major Dominant Countries in the Catechin Market

• United Arab Emirates is forecasted to reach USD 0.8 million by 2034, leading the region with 28.6% share and growing at a CAGR of 5.3%.
• South Africa is expected to attain USD 0.6 million by 2034, accounting for 21.4% of the regional market and expanding at a CAGR of 5.4%.
• Saudi Arabia is projected to secure USD 0.5 million by 2034, representing 17.9% share with a CAGR of 5.5%.
• Egypt is anticipated to grow to USD 0.5 million by 2034, holding 17.9% share and growing at a CAGR of 5.6%.
• Nigeria is expected to reach USD 0.4 million by 2034, capturing 14.2% of the regional market and growing at a CAGR of 5.6%.

Investment Analysis and Opportunities

Investment in the catechin market is gaining momentum, evidenced by increased R&D focus on extraction innovations and application diversification. For example, supercritical fluid extraction and microwave-assisted extraction technologies are being implemented to increase yield and purity—enhancements critical for high-demand sectors like nutraceuticals and cosmetics. In 2024, Asia‑Pacific remains the biggest supplier, with 32.8 % market share in 2019 and continuing strong contributions through 2024. North America, representing 48.3 % of global catechin market share and valued at USD 8.9 million in 2024, demonstrates solid demand built on functional beverage, dietary supplement, and skincare sectors. The growing interest in clean‑label, antioxidant‑rich ingredients across urban and fitness-conscious demographics is driving new market entry and scaling opportunities. Opportunities lie in premium high-purity catechin segments—particularly EGCG (> 94 %) and ECG (46.8 % share)—which are favored in clinical and high-end formulations. Additionally, emerging regions such as the Middle East & Africa and Latin America hold potential through rising urban health awareness and expanding distribution networks. Together, these investment avenues underscore strategic entry points for manufacturers and investors exploring innovative product formulations, expanded regional footprints, and technology-driven differentiation.

New Product Development

Innovation in catechin-based products is surging across applications. In 2023, catechin-based skin health supplements were introduced following research into anti‑aging and elasticity improvements. These products serve growing consumer demand for plant-based skincare solutions. Functional beverages remain a hotspot, with green tea catechins—holding 62.1 % of source share—being integrated into new formats like fortified teas, energy‑boosting drinks, and wellness infusions, aligning with antioxidant and metabolic health trends. Additionally, ECG (46.8 % type share) is being formulated into dietary supplement capsules and powders, enhancing bioactivity and applications in cardiovascular and cognitive health sectors. Cosmetics and personal care segments are leveraging catechins for the first time in high‑performance formulations. Catechin‑infused moisturizers, serums, and skin toners are formulated to deliver antioxidant protection, calming effect, and UV‑protection properties. For instance, product launches in 2023 highlighted the integration of high-purity EGCG in skin serums for anti‑aging benefits. Moreover, nutraceutical innovation is expanding, with targeted supplements combining catechins with probiotic and vitamin complexes to enhance immune and metabolic outcomes. Overall, these developments reflect growing applications of catechin derivatives across beverages, supplements, and skincare—driven by high‑purity types and technology-enabled extraction that supports premium product positioning.

Five Recent Developments

• In December 2023, skin health supplements containing catechin emerged, promising improvements in skin elasticity and hydration via catechin antioxidants.
• In 2024, functional beverages using green tea catechins dominated market sourcing with 62.1 % global share.
• ECG (Epicatechin Gallate) achieved a type-based dominance of 46.8 % in product segmentation in 2024.
• North America accounted for 48.3 % of the global catechin market in 2024, with functional applications—like beverages and supplements—propelling growth.
• The global catechin market valuation reached USD 22.07 million in 2024, highlighting rising market scale and investment interest.

Report Coverage of Catechin Market

This report encompasses an expansive scope of the catechin market, offering comprehensive insights into segmentation, regional dynamics, and innovation trends—with a strong focus on numerical facts and figures. It addresses Type categories including ECG (46.8 %), EGCG (>94 %), and standard catechin (70–80 %) purity types, tracking their respective market shares. Application coverage spans functional beverages (36.6 % share), dietary supplements, daily chemicals (dominant application), and cosmetics—highlighting where catechins are most utilized. Geographic breakdown is detailed, with North America commanding 48.3 % of global share (valued at USD 8.9 million), Asia‑Pacific contributing over 32.8 % in 2019 and maintaining leadership in 2024, Europe and Middle East & Africa as developing markets, along with incremental data from Latin America’s 0.05 billion valuation in 2024. Competitive landscape is covered, offering annotation of top five companies holding around 55 % market share—including Taiyo Green Power and Hunan Sunfull Bio‑tech—along with other key players listed across regions. Novel product developments and functional innovations—such as skin health supplements, high-purity catechins, and functional beverage integration—are highlighted with year markers (2023–2025). Investments, R&D, and regulatory considerations are woven across dynamics, segmentation, and regional outlook, equipping B2B stakeholders with targeted data-driven intelligence essential for strategic decision-making.

Catechin Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 18.54 Million in 2026
Market Size Value By	USD 30.24 Million by 2035
Growth Rate	CAGR of 5.59% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Catechin 70%-80% EGCG (>94%) Others By Application : Beverage Dietary Supplements Daily Chemicals Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample